- Home
- CELU vs AIRT Comparison
CELU vs AIRT Comparison
Compare CELU & AIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELU
- AIRT
- Stock Information
- Founded
- CELU 2016
- AIRT 1980
- Country
- CELU United States
- AIRT United States
- Employees
- CELU N/A
- AIRT N/A
- Industry
- CELU Biotechnology: Pharmaceutical Preparations
- AIRT Air Freight/Delivery Services
- Sector
- CELU Health Care
- AIRT Consumer Discretionary
- Exchange
- CELU Nasdaq
- AIRT Nasdaq
- Market Cap
- CELU 49.9M
- AIRT 53.2M
- IPO Year
- CELU N/A
- AIRT N/A
- Fundamental
- Price
- CELU $2.24
- AIRT $20.00
- Analyst Decision
- CELU
- AIRT
- Analyst Count
- CELU 0
- AIRT 0
- Target Price
- CELU N/A
- AIRT N/A
- AVG Volume (30 Days)
- CELU 231.0K
- AIRT 17.8K
- Earning Date
- CELU 11-07-2024
- AIRT 02-10-2025
- Dividend Yield
- CELU N/A
- AIRT N/A
- EPS Growth
- CELU N/A
- AIRT N/A
- EPS
- CELU N/A
- AIRT N/A
- Revenue
- CELU $48,200,000.00
- AIRT $284,091,000.00
- Revenue This Year
- CELU N/A
- AIRT N/A
- Revenue Next Year
- CELU $233.89
- AIRT N/A
- P/E Ratio
- CELU N/A
- AIRT N/A
- Revenue Growth
- CELU 225.94
- AIRT N/A
- 52 Week Low
- CELU $1.30
- AIRT $12.53
- 52 Week High
- CELU $7.97
- AIRT $30.60
- Technical
- Relative Strength Index (RSI)
- CELU 46.60
- AIRT 50.81
- Support Level
- CELU $2.17
- AIRT $19.56
- Resistance Level
- CELU $2.43
- AIRT $22.50
- Average True Range (ATR)
- CELU 0.26
- AIRT 1.25
- MACD
- CELU -0.01
- AIRT -0.25
- Stochastic Oscillator
- CELU 54.02
- AIRT 20.97
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.
About AIRT Air T Inc.
Air T Inc together with its subsidiaries provides air freight service to the express delivery industry. The company's operating segments include Overnight air cargo, Ground equipment sales, Commercial jet engines, and parts, Corporate, and Others. The company generates maximum revenue from the Commercial Jet Engines and Parts segment.